1-7 of 7
Su-Hyung Park
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade

Seung Hyuck Jeon, Gihoon You, Junsik Park, Youseung Chung, Kyungjin Park, Hyunjoo Kim, Jaehyoung Jeon, Youngkwang Kim, Woo-Chan Son, Da Som Jeong, Eui-Cheol Shin, Jung-Yun Lee, Dai Hoon Han, Jaeho Jung, Su-Hyung Park
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (18): 4155–4166.
https://doi.org/10.1158/1078-0432.CCR-23-2864
Published: 13 September 2024
View article titled, Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8<sup>+</sup> T Cells and Enhances the Efficacy of Anti-PD1 Blockade
Open the PDF for Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8<sup>+</sup> T Cells and Enhances the Efficacy of Anti-PD1 Blockade in another window
Includes: Supplementary data
Journal Articles

CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy

Seung Hyuck Jeon, Minyong Kang, Minwoo Jeon, Youseung Chung, A Reum Kim, Yong Joon Lee, Eui-Soon Kim, Heejin Nam, Junsik Park, Jung-Yun Lee, Eui-Cheol Shin, Seong Il Seo, Su-Hyung Park
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (9): 1794–1806.
https://doi.org/10.1158/1078-0432.CCR-22-1843
Published: 01 May 2023
View article titled, CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy
Open the PDF for CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy in another window
Includes: Supplementary data
Journal Articles

Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma

Hyunsoo Cho, Kyung Hwan Kim, Hoyoung Lee, Chang Gon Kim, Haerim Chung, Yoon Seok Choi, Su-Hyung Park, June-Won Cheong, Yoo Hong Min, Eui-Cheol Shin, Jin Seok Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (10): 2947–2958.
https://doi.org/10.1158/1078-0432.CCR-20-3418
Published: 15 May 2021
View article titled, Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma
Open the PDF for Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Correction: The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors

Kyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, Jiae Koh, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Jaekyung Cheon, Young Joo Min, Su-Hyung Park, Keunchil Park, Myung-Ju Ahn, Eui-Cheol Shin
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (24): 6610.
https://doi.org/10.1158/1078-0432.CCR-20-4231
Published: 15 December 2020
View article titled, Correction: The First-week Proliferative Response of Peripheral Blood PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors
Open the PDF for Correction: The First-week Proliferative Response of Peripheral Blood PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors in another window
Journal Articles

PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors

Minsuk Kwon, Chang Gon Kim, Hoyoung Lee, Hyunsoo Cho, Youngun Kim, Eung Chang Lee, Seong Jin Choi, Junsik Park, In-Ho Seo, Bjarne Bogen, Ik-Chan Song, Deog-Yeon Jo, Jin Seok Kim, Su-Hyung Park, Inhak Choi, Yoon Seok Choi, Eui-Cheol Shin
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (7): 1644–1655.
https://doi.org/10.1158/1078-0432.CCR-19-0267
Published: 01 April 2020
View article titled, PD-1 Blockade Reinvigorates Bone Marrow CD8<sup>+</sup> T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors
Open the PDF for PD-1 Blockade Reinvigorates Bone Marrow CD8<sup>+</sup> T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors in another window
Includes: Supplementary data
Journal Articles

Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8+ T Cells is Determined by Their Differentiation Status in Glioblastoma

Junsik Park, Minsuk Kwon, Kyung Hwan Kim, Tae-Shin Kim, Seon-Hui Hong, Chang Gon Kim, Seok-Gu Kang, Ju Hyung Moon, Eui Hyun Kim, Su-Hyung Park, Jong Hee Chang, Eui-Cheol Shin
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2549–2559.
https://doi.org/10.1158/1078-0432.CCR-18-2564
Published: 15 April 2019
View article titled, Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8<sup>+</sup> T Cells is Determined by Their Differentiation Status in Glioblastoma
Open the PDF for Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8<sup>+</sup> T Cells is Determined by Their Differentiation Status in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors

Kyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, Jiae Koh, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Jaekyung Cheon, Young Joo Min, Su-Hyung Park, Keunchil Park, Myung-Ju Ahn, Eui-Cheol Shin
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (7): 2144–2154.
https://doi.org/10.1158/1078-0432.CCR-18-1449
Published: 01 April 2019
View article titled, The First-week Proliferative Response of Peripheral Blood PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors
Open the PDF for The First-week Proliferative Response of Peripheral Blood PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors in another window
Includes: Supplementary data